Christoph Öhlknecht

Christoph Öhlknecht's work experience includes the role of Head of Protein Science at Arkeon Biotechnologies starting in February 2022. Prior to that, they served as CEO at Cloning Company from January 2021. Christoph also worked as a PHD Student at the University of Natural Resources and Life Sciences, Vienna (BOKU) from June 2017 to November 2020.

Christoph Öhlknecht obtained their Doktor degree in Computersimulation from the University of Natural Resources and Life Sciences, Vienna (BOKU) between the years 2017 and 2020.